Literature DB >> 3881071

Bronchoalveolar lavage: role in the pathogenesis, diagnosis, and management of interstitial lung disease.

R P Daniele, J A Elias, P E Epstein, M D Rossman.   

Abstract

Bronchoalveolar lavage has emerged as a useful technique for the study of pulmonary interstitial disorders. Several types of information are provided by the evaluation of lavage fluid. First, the identification of cellular constituents helps to separate inflammatory processes in which lymphocytes predominate (for example, sarcoidosis, hypersensitivity pneumonitis, and berylliosis) from those in which neutrophils or macrophages predominate (for example, idiopathic pulmonary fibrosis and histiocytosis X). Second, the cells removed during lavage can be studied for their immune properties and function; tested with specific antigens, in diseases such as berylliosis and hypersensitivity pneumonitis; and examined for the presence of unique surface antigens with monoclonal antibodies (for example, histiocytosis X). Third, in conjunction with scanning electron microscopy and electron probe analysis, lavage makes possible the identification of inorganic particles in alveolar macrophages of patients with pneumoconiotic lung disease. Finally, although lavage is still an investigative procedure for most pulmonary disorders, it has an established role in the diagnosis of opportunistic infections in the immunocompromised patient.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3881071     DOI: 10.7326/0003-4819-102-1-93

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  42 in total

1.  Extrinsic allergic alveolitis caused by goose feathers in a duvet.

Authors:  T Haitjema; H van Velzen-Blad; J M van den Bosch
Journal:  Thorax       Date:  1992-11       Impact factor: 9.139

2.  Bronchoalveolar lavage via a modified stomach tube in intubated patients with the acquired immunodeficiency syndrome and diffuse pneumonia.

Authors:  R Minutoli; E Eden; C Brachfeld
Journal:  Thorax       Date:  1990-10       Impact factor: 9.139

3.  Role of bronchoalveolar lavage in the evaluation of interstitial pneumonitis in recipients of bone marrow transplants.

Authors:  H J Milburn; H G Prentice; R M du Bois
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

4.  Predictive value of gallium scan, angiotensin-converting enzyme level, and bronchoalveolar lavage in two-year follow-up of pulmonary sarcoidosis.

Authors:  R P Baughman; R Shipley; C E Eisentrout
Journal:  Lung       Date:  1987       Impact factor: 2.584

5.  Omega-oxidized leukotriene B4 detected in the broncho-alveolar lavage fluid of patients with non-cardiogenic pulmonary edema, but not in those with cardiogenic edema.

Authors:  W Seeger; F Grimminger; M Barden; G Becker; J Lohmeyer; D Heinrich; H G Lasch
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

6.  Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration.

Authors:  Lien Van Hoecke; Emma Richelle Job; Xavier Saelens; Kenny Roose
Journal:  J Vis Exp       Date:  2017-05-04       Impact factor: 1.355

Review 7.  Microfluidic sample preparation for diagnostic cytopathology.

Authors:  Albert J Mach; Oladunni B Adeyiga; Dino Di Carlo
Journal:  Lab Chip       Date:  2013-03-21       Impact factor: 6.799

8.  Tumor necrosis factor production by human sarcoid alveolar macrophages.

Authors:  P R Bachwich; J P Lynch; J Larrick; M Spengler; S L Kunkel
Journal:  Am J Pathol       Date:  1986-12       Impact factor: 4.307

9.  The density of HLA-DR antigen expression on alveolar macrophages is increased in pulmonary sarcoidosis.

Authors:  D A Campbell; R M du Bois; R G Butcher; L W Poulter
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

10.  Pulmonary alveolar macrophages from patients with active sarcoidosis express type IV collagenolytic proteinase. An enzymatic mechanism for influx of mononuclear phagocytes at sites of disease activity.

Authors:  C Agostini; S Garbisa; L Trentin; R Zambello; G Fastelli; M Onisto; A Cipriani; G Festi; D Casara; G Semenzato
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.